1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Oral contraceptive use and breast cancer risk: A cohort study of BRCA1 and BRCA2 mutation carriers
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13 Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Risk of male breast cancer in users of testosterone 5a reductase inhibitors
2016) 2016 Annual Meeting of the American Society of Clinical Oncology In Journal of Clinical Oncology 34(Suppl 15).(
- Contribution to journal › Published meeting abstract
- 2012
-
Mark
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2011
-
Mark
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
- 2001
-
Mark
Gene-expression profiles in hereditary breast cancer
(
- Contribution to journal › Article
- 2000
-
Mark
Tumour biology of a breast cancer at least partly reflects the biology of the tissue/epithelial cell of origin at the time of initiation - a hypothesis
(
- Contribution to journal › Article
- 1999
-
Mark
Guidelines for follow-up of women at high risk for inherited breast cancer : consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
(
- Contribution to journal › Article
- 1998
-
Mark
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease
(
- Contribution to journal › Article
-
Mark
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group
(
- Contribution to journal › Article